Diabetes mellitus and immunization

Česká verzia

Authors: J. Beran
Authors place of work: Klinika infekčních nemocí Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jiří Beran, CSc., a Subkatedra tropické a cestovní medicíny IPVZ, Praha, přednosta prof. MUDr. Jiří Beran, CSc.
Published in the journal: Vnitř Lék 2006; 52(5): 438-442
Category: Diabetes and other subjects (infection, dermatovenerology and rheumatology) Hradec Králové 3 to 4 June 2005

Summary

Principles of prevention of infectious diseases have been known for several thousands of years. One of the most significant tools of infection prophylaxis is immunization. Vaccines containing thymus-dependent antigens produce massive and complex immune response and feature immunologic memory. That is why they can successfully protect patients with diabetes. Lately, it has been thought by general public and even experts that application of vaccines within national immunization programmes is one of the etiopathogenetic factors in the development of type 1 diabetes mellitus (DM). However, analysis of extensive studies performed by the experts of the Institute for Vaccine Safety proved that there is no positive or negative impact of immunization on the development of type 1 diabetes mellitus. The basic vaccinations recommended for diabetics include immunizations against influenza, pneumococcal infections, tetanus and viral hepatitis B. Other vaccines are administered only after individual assessment of benefits and risks for the diabetic patient. Most often, these are vaccinations against viral hepatitis A, tick-borne encephalitis, meningococcal infections and other infections that put in risk diabetic patients travelling abroad.

Key words:
vaccination – immunization – diabetes mellitus

Zdroje

1. Andrews RM, Skull SA, Byrnes GB et al. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria. Commun Dis Intell 2005; 29: 283-288.

2. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years and persons aged 18 - 64 years with diabetes or asthma - United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 1007-1012.

3. Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. The Institute for Vaccine Safety Diabetes Workshop Panel. Pediatr Infect Dis J 1999; 18: 217-222.

4. Bartošová D et al. Dětské infekční nemoci. Trendy soudobé pediatrie. Vol 2. Praha: Galén, 2003.

5. Belloni C, Avanzini MA, De Silvestri A et al. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine. Pediatrics 2002; 110(Suppl E): e4.

6. Beran J. Očkování a imunitní systém. Klinická mikrobiologie a infekční lékařství 2002; 8: 251-262.

7. Beran J, Havlík J. Chřipka - stále aktuální problém. Postgraduální medicína 2003; 5: 949-954.

8. Beran J, Cabrnochová H, Kohl I et al. Očkování v terénní praxi. Postgraduální medicína 2003; 1: 1-62.

9. Beran J, Chlíbek R. Nověji zaváděné očkovací látky proti infekčním chorobám. Trendy ve farmakoterapii. Zdravotnické noviny 2001; 4: 25-28.

10. DeStefano F, Mullooly JP, Okoro CA et al. Vaccine Safety Datalink Team. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001; 108: E112.

11. Ferenčík M, Rovenský J, Maťha V. Ilustrovaný imunologický slovník. Praha: Galén 2004.

12. Göpfertová D. Očkování včera. Remedia-Forum medicinae 1999; 1: 8-18.

13. Havlík J et al. Infekční nemoci. Praha: Galén 2002.

14. House DV, Winter WE. Autoimmune diabetes. The role of autoantibody markers in the prediction and prevention of insulin-dependent diabetes mellitus. Clin Lab Med 1997; 17: 499-545.

15. Hummel M, Fuchtenbusch M, Schenker M et al. No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care 2000; 23: 969-974.

16. Montgomery SM, Ehlin AG, Ekbom A et al. Pertussis infection in childhood and subsequent type 1 diabetes mellitus. Diabet Med 2002; 19: 986-993.

17. Plotkin, S, Orenstein WA. Vaccines. 4th edition. Philadelphia: WB Saunders 2004.